Advertisement

Effect of Novel Programming on Inappropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Very Low Ejection Fraction (from A MADIT-RIT)

Published:September 06, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.07.018
      The Multicenter Automatic Defibrillator Implantation Trial – Reduce Inappropriate Therapy showed a significant reduction in the risk of inappropriate therapy in patients with a programmed high-rate cutoff ≥200 beats per minute or delayed therapy for events ≥170 beats per minute compared with conventional programming. We aimed to characterize outcomes by left ventricular ejection fraction (LVEF) ranges for patients with high-rate, delayed, or conventional implantable cardioverter-defibrillator programming. We assessed the effect of LVEF (LVEF <15%, LVEF 15% to 25%, LVEF >25%) on the risk of inappropriate conventional implantable cardioverter-defibrillator therapy and death in Multicenter Automatic Defibrillator Implantation Trial – Reduce Inappropriate Therapy. Inappropriate therapies and death were independently evaluated by the adjudication committee. Statistical methods involved Kaplan-Meier time-to-event graphs and Cox proportional hazards regression analyses. The study involved 140 patients (9%) with LVEF 15%, 585 with LVEF 15% to 25% (39%), and 774 with LVEF >25% (52%). High-rate or delayed programming significantly reduced the risk of inappropriate therapy compared with conventional programming in patients with all LVEFs (p <0.001 for all LVEF). Patients with LVEF <15% had an exceptional 97% lower risk of inappropriate therapy, with high-rate programming than conventional programming (hazard ratio 0.028, p = 0.001), without an increase in mortality. High-rate and delayed programming is superior to conventional programming in all LVEF ranges, without adverse effects.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Moss AJ
        • Zareba W
        • Hall WJ
        • Klein H
        • Wilber DJ
        • Cannom DS
        • Daubert JP
        • Higgins SL
        • Brown MW
        • Andrews ML
        Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
        N Engl J Med. 2002; 346: 877-883
        • van Rees JB
        • Borleffs CJ
        • de Bie MK
        • Stijnen T
        • van Erven L
        • Bax JJ
        • Schalij MJ.
        Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.
        J Am Coll Cardiol. 2011; 57: 556-562
        • Theuns DA
        • Klootwijk AP
        • Simoons ML
        • Jordaens LJ.
        Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy.
        Am J Cardiol. 2005; 95: 271-274
        • Hreybe H
        • Ezzeddine R
        • Barrington W
        • Bazaz R
        • Jain S
        • Ngwu O
        • Saba S.
        Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks.
        Am J Cardiol. 2006; 97: 544-546
        • Daimee UA
        • Vermilye K
        • Rosero S
        • Schuger CD
        • Daubert JP
        • Zareba W
        • McNitt S
        • Polonsky B
        • Moss AJ
        • Kutyifa V.
        Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT-RIT substudy.
        Pacing Clin Electrophysiol. 2017; 40: 1405-1411
        • Moss AJ
        • Schuger C
        • Beck CA
        • Brown MW
        • Cannom DS
        • Daubert JP
        • Estes 3rd, NA
        • Greenberg H
        • Hall WJ
        • Huang DT
        • Kautzner J
        • Klein H
        • McNitt S
        • Olshansky B
        • Shoda M
        • Wilber D
        • Zareba W
        • MADIT-RIT Trial Investigators
        Reduction in inappropriate therapy and mortality through ICD programming.
        N Engl J Med. 2012; 367: 2275-2283
        • Kloppe A
        • Proclemer A
        • Arenal A
        • Lunati M
        • Martìnez Ferrer JB
        • Hersi A
        • Gulaj M
        • Wijffels MC
        • Santi E
        • Manotta L
        • Mangoni L
        • Gasparini M
        Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for nonsustained Arrhythmias in ICD Patients III (Advance III) trial.
        Circulation. 2014; 130: 308-314
        • Saeed M
        • Hanna I
        • Robotis D
        • Styperek R
        • Polosajian L
        • Khan A
        • Alonso J
        • Nabutovsky Y
        • Neason C.
        Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study.
        J Cardiovasc Electrophysiol. 2014; 25: 52-59
        • Wilkoff BL
        • Kühlkamp V
        • Volosin K
        • Ellenbogen K
        • Waldecker B
        • Kacet S
        • Gillberg JM
        • DeSouza CM.
        Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations.
        Circulation. 2001; 103: 381-386
        • Kotecha D
        • Chudasama R
        • Lane DA
        • Kirchhof P
        • Lip GY.
        Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes.
        Int J Cardiol. 2016; 203: 660-666
        • Daubert JP
        • Zareba W
        • Cannom DS
        • McNitt S
        • Rosero SZ
        • Wang P
        • Schuger C
        • Steinberg JS
        • Higgins SL
        • Wilber DJ
        • Klein H
        • Andrews ML
        • Hall WJ
        • Moss AJ
        • MADIT II Investigators
        Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
        J Am Coll Cardiol. 2008; 51: 1357-1365
        • Koneru JN
        • Swerdlow CD
        • Wood MA
        • Ellenbogen KA.
        Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming.
        Circ Arrhythm Electrophysiol. 2011; 4: 778-790
        • Kutyifa V
        • Daubert JP
        • Olshansky B
        • Huang DT
        • Zhang C
        • Ruwald AC
        • McNitt S
        • Zareba W
        • Moss AJ
        • Schuger C.
        Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: result of the MADIT-RIT efficacy analysis.
        Heart Rhythm. 2015; 12: 2030-2037
        • Hasdemir C
        • Shah N
        • Rao AP
        • Acosta H
        • Matsudaira K
        • Neas BR
        • Reynolds DW
        • Po S
        • Lazzara R
        • Beckman KJ.
        Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks.
        J Cardiovasc Electrophysiol. 2002; 13: 144-150
        • Deyell MW
        • Qi A
        • Chakrabarti S
        • Yeung-Lai-Wah JA
        • Tung S
        • Khoo C
        • Bennett MT
        • Qian H
        • Kerr CR.
        Prognostic impact of inappropriate defibrillator shocks in a population cohort.
        Heart. 2013; 99: 1250-1255
        • Pedersen SS
        • VAN DEN Berg M
        • Erdman RA
        • VAN Son J
        • Jordaens L
        • Theuns DA
        Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality.
        Pacing Clin Electrophysiol. 2009; 32: 184-192